The ASCPT Member Spotlight is a forum to recognize and thank a member of ASCPT who has supported the Society's endeavors. We also highlight the Member of the Month, along with two other members, in each issue of Clinical Pharmacology & Therapeutics. We hope you will enjoy learning about fellow members and as always, encourage your participation in Society events and activities.
Shruti Agrawal, PhD: February Member Spotlight
Previous Members of the Month
|ASCPT is proud to recognize Shruti Agrawal, PhD as the February 2017 Member of the Month.
Shruti Agrawal, PhD, Director, Bristol-Myers Squibb Co., Clinical Pharmacology and Pharmacometrics, East Windsor, NJ
Dr. Agrawal learned about ASCPT through interactions with colleagues after joining Bristol-Myers Squibb Co. She was also attracted to join ASCPT by Clinical Pharmacology and Therapeutics (CPT). She explains that she was attracted to ASCPT during a brainstorming session with colleagues regarding opportunities and challenges in biologic drug development vis à vis small molecule in 2010. This led to co-chairing a session titled “Clinical Pharmacology Strategies for Accelerated Development of Biologics” at ASCPT 2013. Since then ASCPT has played a critical role in advancing her career in clinical pharmacology. She cites these specific benefits: the Annual Meeting, continuous learning platforms throughout the year, and scientific publications such as CPT, CPT: PSP, and more recently CTS. They help expand the knowledge of clinical pharmacology advancements that can be applied in the drug development decision-making and regulatory interactions. ASCPT membership also provides avenues to interact with industry and regulatory colleagues, and contribute to various communities and networks.
When asked about her favorite aspect of membership, Dr. Agrawal identifies three aspects. The Annual Meeting, the journals, and volunteer activities are all her favorites. She explains that the Annual Meeting is a venue for face-to-face interactions and is an annual “learning shot”; journals are a platform for key advancements in clinical pharmacology on a regular basis; and volunteer activity provides visibility within the field and also provides a satisfaction of contribution to the Society.
ASCPT is a unique organization with a mix of academia, clinical pharmacology, pharmacometricians, and clinicians and regulatory colleagues that makes the Society come up with a very balanced approach towards translational research for drug development. This mix of representation is not seen in any other organizations. The current challenges, opportunities and advancement is then discussed in round tables with the very balanced and enthusiastic membership representing various functional groups in drug development.
Dr. Agrawal encourages the younger generation to get involved in volunteer activities through ASCPT networks and communities, and also take advantage of the benefits from mentoring sessions. ASCPT is a great venue in expanding clinical pharmacology perspectives early on in the career, and provides interactions with colleagues to help advance the career.
Dr. Agrawal has been a member of ASCPT since 2012. She is currently a member of the QP Hot Topics Initiative and serves as the communication lead for the Oncology Community.